The Impact of Pseudomonas aeruginosa Infection in Adult Cystic Fibrosis Patients-A Single Polish Centre Study
- PMID: 38133323
- PMCID: PMC10748198
- DOI: 10.3390/pathogens12121440
The Impact of Pseudomonas aeruginosa Infection in Adult Cystic Fibrosis Patients-A Single Polish Centre Study
Abstract
Background: Pseudomonas aeruginosa (PA) is one of the most predominant pathogens of lung infections, often causing exacerbations in adult patients with cystic fibrosis (CF).
Materials and methods: Microbiological characterization of 74 PA isolates and to evaluate the correlations between the bacterial features and 44 adult Polish CF cohort clinical parameters.
Results: The most common variant in the CF transmembrane conductance regulator (CFTR) gene was F508del (76.3%), followed by 3849+10kbC>T (26.3%). A total of 39.4% of the PA isolates showed multiple resistances. In patients with parameters pointing to a decline in lung function, there was a statistically significant moderate correlation with β-lactam resistance and a weak correlation between hospital frequency and colistin resistance. The mucoidity did not correlate with the biofilm formation ability, which showed 41.9% of the isolates. Proteolytic activity, observed in 60.8% of the clinical isolates, was weakly associated with motility detected in 78.4% of the strains. The genetic profiles of the PA were highly heterogeneous, and a weak positive correlation was established between cluster group and biofilm formation.
Conclusion: The findings suggest that there is a high variety in P. aeruginosa populations in adult CF patients. There is a need to monitor PA strains in groups of patients with cystic fibrosis, in particular, in terms of the occurrence of antibiotic resistance related to a decline in lung function.
Keywords: Pseudomonas aeruginosa; antimicrobial drug resistance; cystic fibrosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 36990700 Chinese.
-
Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.J Clin Pharm Ther. 2018 Feb;43(1):92-100. doi: 10.1111/jcpt.12616. Epub 2017 Sep 22. J Clin Pharm Ther. 2018. PMID: 29293275
-
Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.J Clin Pharm Ther. 2018 Dec;43(6):836-843. doi: 10.1111/jcpt.12722. Epub 2018 Jun 29. J Clin Pharm Ther. 2018. PMID: 29959786
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
-
Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.Pediatr Pulmonol. 2000 Nov;30(5):413-24. doi: 10.1002/1099-0496(200011)30:5<413::aid-ppul8>3.0.co;2-9. Pediatr Pulmonol. 2000. PMID: 11064433 Review.
Cited by
-
Diversification of Pseudomonas aeruginosa After Inhaled Tobramycin Therapy of Cystic Fibrosis Patients: Genotypic and Phenotypic Characteristics of Paired Pre- and Post-Treatment Isolates.Microorganisms. 2025 Mar 24;13(4):730. doi: 10.3390/microorganisms13040730. Microorganisms. 2025. PMID: 40284567 Free PMC article.
-
Genomic Insights into Vietnamese Extended-Spectrum β-Lactamase-9-Producing Extensively Drug-Resistant Pseudomonas aeruginosa Isolates Belonging to the High-Risk Clone ST357 Obtained from Bulgarian Intensive Care Unit Patients.Pathogens. 2024 Aug 25;13(9):719. doi: 10.3390/pathogens13090719. Pathogens. 2024. PMID: 39338911 Free PMC article.
-
Effects of CFTR Modulators on Pseudomonas aeruginosa Infections in Cystic Fibrosis.Infect Dis Rep. 2025 Jul 7;17(4):80. doi: 10.3390/idr17040080. Infect Dis Rep. 2025. PMID: 40700326 Free PMC article. Review.
References
-
- Cystic Fibrosis Foundation Patient Registry 2020 Annual Data Report. [(accessed on 14 April 2022)]. Available online: https://www.cff.org/sites/default/files/2021-11/Patient-Registry-Annual-....
-
- Kidd T.J., Ramsay K.A., Vidmar S., Carlin J.B., Bell S.C., Wainwright C.E., Grimwood K., Francis P.W., Dakin C., Cheney J., et al. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years. J. Cyst. Fibros. 2015;14:361–369. doi: 10.1016/j.jcf.2014.12.007. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases